Marcellusi, A., C. Bini, L. Fioravanti, S. Ripoli, and P. Morelli. “Cost-Effectiveness of Brentuximab Vedotin Plus Chemotherapy As Frontline Treatment of Systemic Anaplastic Large Cell Lymphoma in Italy”. Global and Regional Health Technology Assessment, vol. 12, no. 1, Apr. 2025, pp. 106-17, doi:10.33393/grhta.2025.3306.